{"transactions":[{"id":1361569,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-11-18T16:06:19.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":584646,"price":3.2499,"value":1900041.0354,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These pre-funded warrants are currently exercisable, subject to a 39.99% beneficial ownership limitation on the reporting persons, at an initial exercise price of $0.0001 and will expire on the date they are exercised in full."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. (\"FCMI\") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":584646,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":584646},"source":{"system":"sec-edgar","filing":"0001062993-24-019266","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324019266/form4.xml","form_type":"4"}},{"id":1361568,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-18T16:06:19.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":30756,"price":3.25,"value":99957.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. (\"FCMI\") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1051389,"source":{"system":"sec-edgar","filing":"0001062993-24-019266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324019266/form4.xml","form_type":"4"}},{"id":1361550,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-18T16:05:50.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":46153,"price":3.25,"value":149997.25,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":297941,"source":{"system":"sec-edgar","filing":"0001062993-24-019265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324019265/form4.xml","form_type":"4"}},{"id":1401473,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":170475,"price":0.125,"value":21309.375,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":170475,"derivative":{"exercise_price":5.636,"exercise_date":"2024-09-18","expiration_date":"2029-09-18","underlying":"Common Stock","underlying_shares":170475},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401472,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":35715,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2023-10-03","expiration_date":"2028-10-03","underlying":"Common Stock","underlying_shares":35715},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401471,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":9768,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This warrant was originally reported on Form 4 with an exercise price of $32.76. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2023-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":9768},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401470,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":29557,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2024-02-08","expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":29557},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401469,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":38610,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This warrant was originally reported on Form 4 with an exercise price of $7.64. Pursuant to a warrant inducement agreement by and between the issuer and Vaccinex (Rochester) L.L.C. dated September 17, 2024 (the \"Warrant Inducement Agreement\"), the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2024-03-28","expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":38610},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401468,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":35715,"price":5.636,"value":201289.74,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":251788,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401467,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":9768,"price":5.636,"value":55052.448,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This warrant was originally reported on Form 4 with an exercise price of $32.76. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":216073,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401466,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":29557,"price":5.636,"value":166583.252,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":206305,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401465,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":38610,"price":5.636,"value":217605.96,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This warrant was originally reported on Form 4 with an exercise price of $7.64. Pursuant to a warrant inducement agreement by and between the issuer and Vaccinex (Rochester) L.L.C. dated September 17, 2024 (the \"Warrant Inducement Agreement\"), the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":176748,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401516,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:11:30.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":653210,"price":0.125,"value":81651.25,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. (\"FCMI\") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":653210,"derivative":{"exercise_price":5.636,"exercise_date":"2024-09-18","expiration_date":"2029-09-18","underlying":"Common Stock","underlying_shares":653210},"source":{"system":"sec-edgar","filing":"0001062993-24-016838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324016838/form4.xml","form_type":"4"}},{"id":1401515,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:11:30.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":25723,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636. FCMI partially exercised this warrant for 25,723 shares at an exercise price of $5.636 per share and pre-funded the remaining 92,504 shares at a price of $5.635. The exercise price for the remaining 92,504 shares underlying this warrant was subsequently adjusted to $0.001."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. (\"FCMI\") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":92504,"derivative":{"exercise_price":0.001,"exercise_date":"2024-02-08","expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":25723},"source":{"system":"sec-edgar","filing":"0001062993-24-016838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324016838/form4.xml","form_type":"4"}},{"id":1401514,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:11:30.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":214286,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to a warrant inducement agreement by and between the issuer and FCMI dated September 17, 2024 (the \"Warrant Inducement Agreement\"), the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. (\"FCMI\") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2023-10-03","expiration_date":"2028-10-03","underlying":"Common Stock","underlying_shares":214286},"source":{"system":"sec-edgar","filing":"0001062993-24-016838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324016838/form4.xml","form_type":"4"}},{"id":1401513,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:11:30.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":25723,"price":5.636,"value":144974.828,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636. FCMI partially exercised this warrant for 25,723 shares at an exercise price of $5.636 per share and pre-funded the remaining 92,504 shares at a price of $5.635. The exercise price for the remaining 92,504 shares underlying this warrant was subsequently adjusted to $0.001."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. (\"FCMI\") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1020633,"source":{"system":"sec-edgar","filing":"0001062993-24-016838","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324016838/form4.xml","form_type":"4"}},{"id":1401512,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:11:30.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":214286,"price":5.636,"value":1207715.896,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to a warrant inducement agreement by and between the issuer and FCMI dated September 17, 2024 (the \"Warrant Inducement Agreement\"), the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. (\"FCMI\") and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":994910,"source":{"system":"sec-edgar","filing":"0001062993-24-016838","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324016838/form4.xml","form_type":"4"}},{"id":1434657,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T16:30:45.000Z","date":"2024-08-09","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":4.51,"value":451.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":780624,"source":{"system":"sec-edgar","filing":"0001062993-24-014976","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324014976/form4.xml","form_type":"4"}},{"id":1438660,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-07T16:04:52.000Z","date":"2024-08-06","kind":"purchase","planned":false,"acquired":true,"shares":2753,"price":4.92,"value":13544.76,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":780524,"source":{"system":"sec-edgar","filing":"0001062993-24-014577","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324014577/form4.xml","form_type":"4"}},{"id":1438659,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-07T16:04:52.000Z","date":"2024-08-05","kind":"purchase","planned":false,"acquired":true,"shares":3653,"price":4.6,"value":16803.8,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":777771,"source":{"system":"sec-edgar","filing":"0001062993-24-014577","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324014577/form4.xml","form_type":"4"}},{"id":1442714,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-02T16:05:32.000Z","date":"2024-08-01","kind":"purchase","planned":false,"acquired":true,"shares":11703,"price":4.72,"value":55238.16,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":774118,"source":{"system":"sec-edgar","filing":"0001062993-24-014364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324014364/form4.xml","form_type":"4"}},{"id":1444200,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T16:05:16.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":16128,"price":7.396,"value":119282.688,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 to $7.40, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":762415,"source":{"system":"sec-edgar","filing":"0001062993-24-014289","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324014289/form4.xml","form_type":"4"}},{"id":1444199,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T16:05:16.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":83243,"price":6.41,"value":533587.63,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.11 to $7.06, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":746287,"source":{"system":"sec-edgar","filing":"0001062993-24-014289","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324014289/form4.xml","form_type":"4"}},{"id":1444198,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T16:05:16.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":100629,"price":5.738,"value":577409.202,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $6.10, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":663044,"source":{"system":"sec-edgar","filing":"0001062993-24-014289","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324014289/form4.xml","form_type":"4"}},{"id":1496465,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T16:31:14.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":861,"price":5.195,"value":4472.895,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.20. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":562415,"source":{"system":"sec-edgar","filing":"0001062993-24-011556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324011556/form4.xml","form_type":"4"}},{"id":1496464,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T16:31:14.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":957,"price":4.95,"value":4737.15,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":561554,"source":{"system":"sec-edgar","filing":"0001062993-24-011556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324011556/form4.xml","form_type":"4"}},{"id":1517609,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:36:35.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":1341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4."},{"field":"date","element":"transactionDate","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date."}],"balance_after":1341,"derivative":{"exercise_price":8.21,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":1341},"source":{"system":"sec-edgar","filing":"0001062993-24-010189","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000106299324010189/form4a.xml","form_type":"4/A","original_submission_date":"2024-03-22"}},{"id":1517789,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91080,"kind":"person","name":"Sanchez Jill","position":1,"cik":"0002015024","reported_name":"Sanchez Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:35:52.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4."},{"field":"date","element":"transactionDate","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date."}],"balance_after":805,"derivative":{"exercise_price":8.21,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":805},"source":{"system":"sec-edgar","filing":"0001062993-24-010187","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015024/000106299324010187/form4a.xml","form_type":"4/A","original_submission_date":"2024-03-22"}},{"id":1517709,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91078,"kind":"person","name":"Evans Elizabeth E.","position":1,"cik":"0001863447","reported_name":"Evans Elizabeth E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:35:16.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":1341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4."},{"field":"date","element":"transactionDate","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date."}],"balance_after":1341,"derivative":{"exercise_price":8.21,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":1341},"source":{"system":"sec-edgar","filing":"0001062993-24-010186","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863447/000106299324010186/form4a.xml","form_type":"4/A","original_submission_date":"2024-03-22"}},{"id":1517183,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:34:50.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":1877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $9.15 that was listed in the original Form 4."},{"field":"date","element":"transactionDate","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $9.15 that was listed in the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Due to an administrative error, the original Form 4 mistakenly listed the stock option expiration date as March 20, 2029. The expiration date is actually March 21, 2034."}],"balance_after":1877,"derivative":{"exercise_price":8.21,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":1877},"source":{"system":"sec-edgar","filing":"0001062993-24-010185","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324010185/form4a.xml","form_type":"4/A","original_submission_date":"2024-03-22"}},{"id":1517184,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":89874,"kind":"person","name":"Yanni Barbara","position":1,"cik":"0001610561","reported_name":"Yanni Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:33:55.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":10108,"derivative":{"exercise_price":5.75,"exercise_date":"2025-05-10","underlying":"Common Stock","underlying_shares":10108},"source":{"system":"sec-edgar","filing":"0001062993-24-010184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324010184/form4.xml","form_type":"4"}},{"id":1517181,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:33:30.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":10108,"derivative":{"exercise_price":5.75,"exercise_date":"2025-05-10","underlying":"Common Stock","underlying_shares":10108},"source":{"system":"sec-edgar","filing":"0001062993-24-010183","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324010183/form4.xml","form_type":"4"}},{"id":1517180,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T16:33:30.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":543,"price":5.75,"value":3122.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these restricted shares in lieu of $3,125 for retainer and meeting fees during the first quarter of 2024."}],"balance_after":543,"source":{"system":"sec-edgar","filing":"0001062993-24-010183","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324010183/form4.xml","form_type":"4"}},{"id":1518296,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:33:12.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":10108,"derivative":{"exercise_price":5.75,"exercise_date":"2025-05-10","underlying":"Common Stock","underlying_shares":10108},"source":{"system":"sec-edgar","filing":"0001062993-24-010182","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/941871/000106299324010182/form4.xml","form_type":"4"}},{"id":1518295,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:33:12.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":2685,"price":3.96,"value":10632.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $10,625 for retainer and meeting fees during the first quarter of 2024. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2685,"derivative":{"exercise_price":5.75,"exercise_date":"2024-05-10","expiration_date":"2034-05-10","underlying":"Common Stock","underlying_shares":2685},"source":{"system":"sec-edgar","filing":"0001062993-24-010182","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/941871/000106299324010182/form4.xml","form_type":"4"}},{"id":1517661,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91077,"kind":"person","name":"Stecyk Chrystyna Bedrij","position":1,"cik":"0001811625","reported_name":"Stecyk Chrystyna Bedrij","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:32:48.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":10108,"derivative":{"exercise_price":5.75,"exercise_date":"2025-05-10","underlying":"Common Stock","underlying_shares":10108},"source":{"system":"sec-edgar","filing":"0001062993-24-010181","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811625/000106299324010181/form4.xml","form_type":"4"}},{"id":1517608,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:32:24.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":10108,"derivative":{"exercise_price":5.75,"exercise_date":"2025-05-10","underlying":"Common Stock","underlying_shares":10108},"source":{"system":"sec-edgar","filing":"0001062993-24-010179","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299324010179/form4.xml","form_type":"4"}},{"id":1517607,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:32:24.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":2211,"price":3.96,"value":8755.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2024. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2211,"derivative":{"exercise_price":5.75,"exercise_date":"2024-05-10","expiration_date":"2034-05-10","underlying":"Common Stock","underlying_shares":2211},"source":{"system":"sec-edgar","filing":"0001062993-24-010179","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299324010179/form4.xml","form_type":"4"}},{"id":1537523,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-22T16:33:17.000Z","date":"2024-04-19","kind":"purchase","planned":false,"acquired":true,"shares":282,"price":4.73,"value":1333.86,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":560597,"source":{"system":"sec-edgar","filing":"0001062993-24-008643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324008643/form4.xml","form_type":"4"}},{"id":1556035,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-04-01T20:54:14.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":38610,"price":7.77,"value":299999.7,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":38610,"derivative":{"exercise_price":7.64,"exercise_date":"2024-03-28","expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":38610},"source":{"system":"sec-edgar","filing":"0001062993-24-007661","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324007661/form4.xml","form_type":"4"}},{"id":1556034,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T20:54:14.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":38610,"price":7.77,"value":299999.7,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":138138,"source":{"system":"sec-edgar","filing":"0001062993-24-007661","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324007661/form4.xml","form_type":"4"}},{"id":1556090,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-04-01T20:53:49.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":102960,"price":7.77,"value":799999.2,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":102960,"derivative":{"exercise_price":7.64,"exercise_date":"2024-03-28","expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":102960},"source":{"system":"sec-edgar","filing":"0001062993-24-007660","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324007660/form4.xml","form_type":"4"}},{"id":1556089,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T20:53:49.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":102960,"price":7.77,"value":799999.2,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":560315,"source":{"system":"sec-edgar","filing":"0001062993-24-007660","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324007660/form4.xml","form_type":"4"}},{"id":1563570,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91078,"kind":"person","name":"Evans Elizabeth E.","position":1,"cik":"0001863447","reported_name":"Evans Elizabeth E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T16:33:10.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":1341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date."}],"balance_after":1341,"derivative":{"exercise_price":8.32,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":1341},"source":{"system":"sec-edgar","filing":"0001062993-24-006960","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863447/000106299324006960/form4.xml","form_type":"4"}},{"id":1563434,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T16:32:38.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":1341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date."}],"balance_after":1341,"derivative":{"exercise_price":8.32,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":1341},"source":{"system":"sec-edgar","filing":"0001062993-24-006959","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000106299324006959/form4.xml","form_type":"4"}},{"id":1563708,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91080,"kind":"person","name":"Sanchez Jill","position":1,"cik":"0002015024","reported_name":"Sanchez Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T16:31:55.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 30, 2024 grant date."}],"balance_after":805,"derivative":{"exercise_price":8.32,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":805},"source":{"system":"sec-edgar","filing":"0001062993-24-006958","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2015024/000106299324006958/form4.xml","form_type":"4"}},{"id":1563199,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T16:31:19.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":1877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date."}],"balance_after":1877,"derivative":{"exercise_price":9.15,"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":1877},"source":{"system":"sec-edgar","filing":"0001062993-24-006957","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324006957/form4.xml","form_type":"4"}},{"id":1651374,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-02-09T16:34:03.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":413793,"price":0.725,"value":299999.925,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":413793,"derivative":{"exercise_price":1,"exercise_date":"2024-02-08","expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":413793},"source":{"system":"sec-edgar","filing":"0001062993-24-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324002770/form4.xml","form_type":"4"}},{"id":1651373,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T16:34:03.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":413793,"price":0.725,"value":299999.925,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1393392,"source":{"system":"sec-edgar","filing":"0001062993-24-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324002770/form4.xml","form_type":"4"}},{"id":1651405,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-02-09T16:32:53.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":1655172,"price":0.725,"value":1199999.7,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1655172,"derivative":{"exercise_price":1,"exercise_date":"2024-02-08","expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":1655172},"source":{"system":"sec-edgar","filing":"0001062993-24-002769","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324002769/form4.xml","form_type":"4"}},{"id":1651404,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T16:32:53.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":1655172,"price":0.725,"value":1199999.7,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":6402966,"source":{"system":"sec-edgar","filing":"0001062993-24-002769","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299324002769/form4.xml","form_type":"4"}},{"id":1698477,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-28T16:31:17.000Z","date":"2023-12-26","kind":"sale","planned":false,"acquired":false,"shares":3149,"price":0.72,"value":2267.28,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-23-023239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323023239/form4.xml","form_type":"4"}},{"id":1713870,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-12T16:31:18.000Z","date":"2023-12-08","kind":"sale","planned":false,"acquired":false,"shares":1334,"price":0.67,"value":893.78,"ownership":{"direct":true},"balance_after":3149,"source":{"system":"sec-edgar","filing":"0001062993-23-022436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323022436/form4.xml","form_type":"4"}},{"id":1749498,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-11-03T16:29:52.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":136752,"price":0.125,"value":17094.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":136752,"derivative":{"exercise_price":2.34,"exercise_date":"2023-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":136752},"source":{"system":"sec-edgar","filing":"0001062993-23-020103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323020103/form4.xml","form_type":"4"}},{"id":1755247,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-25T16:30:44.000Z","date":"2023-10-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11291,"price":0.77,"value":8694.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This option was canceled by mutual agreement of the reporting person and Vaccinex, Inc. The reporting person received $8,750 as consideration for the cancellation, which represents the reporting person's retainer and meeting fees during the third quarter of 2023."}],"balance_after":0,"derivative":{"exercise_price":1.13,"exercise_date":"2023-09-29","expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":11291},"source":{"system":"sec-edgar","filing":"0001062993-23-019700","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323019700/form4.xml","form_type":"4"}},{"id":1764280,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":1,"value":500000.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":500000,"derivative":{"exercise_price":1,"exercise_date":"2023-10-03","expiration_date":"2028-10-03","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764279,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.973,"value":4865.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9501 to $0.9898, inclusive. Mr. Zauderer undertakes to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":22116,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764278,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.93,"value":4650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9265 to $0.9399, inclusive. Mr. Zauderer undertakes to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17116,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764277,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":1,"value":500000.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":979599,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764292,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-10-05T16:30:55.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":3000000,"price":1,"value":3000000.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":3000000,"derivative":{"exercise_price":1,"exercise_date":"2023-10-03","expiration_date":"2028-10-03","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001062993-23-019061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299323019061/form4.xml","form_type":"4"}},{"id":1764291,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:30:55.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":3000000,"price":1,"value":3000000.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4747794,"source":{"system":"sec-edgar","filing":"0001062993-23-019061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299323019061/form4.xml","form_type":"4"}},{"id":1764353,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-05T16:30:13.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":11291,"price":0.77,"value":8694.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":11291,"derivative":{"exercise_price":1.13,"exercise_date":"2023-09-29","expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":11291},"source":{"system":"sec-edgar","filing":"0001062993-23-019059","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323019059/form4.xml","form_type":"4"}},{"id":1764352,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-05T16:30:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2414,"price":3.62,"value":8738.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2414,"derivative":{"exercise_price":5.34,"exercise_date":"2023-06-30","expiration_date":"2033-06-27","underlying":"Common Stock","underlying_shares":2414},"source":{"system":"sec-edgar","filing":"0001062993-23-019059","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323019059/form4.xml","form_type":"4"}},{"id":1773848,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-25T16:12:22.000Z","date":"2023-09-22","kind":"grant","planned":false,"acquired":true,"shares":2051282,"price":0.156,"value":319999.992,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":7193973,"source":{"system":"sec-edgar","filing":"0001062993-23-018438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323018438/form4.xml","form_type":"4"}},{"id":1891292,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T16:33:20.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":6711552,"price":0.3743,"value":2512133.9136,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":26216904,"source":{"system":"sec-edgar","filing":"0001062993-23-011230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299323011230/form4.xml","form_type":"4"}},{"id":1893666,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91077,"kind":"person","name":"Stecyk Chrystyna Bedrij","position":1,"cik":"0001811625","reported_name":"Stecyk Chrystyna Bedrij","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T16:33:01.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":143848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":143848,"derivative":{"exercise_price":0.41,"exercise_date":"2024-05-11","underlying":"Common Stock","underlying_shares":143848},"source":{"system":"sec-edgar","filing":"0001062993-23-011116","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811625/000106299323011116/form4.xml","form_type":"4"}},{"id":1893602,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T16:32:42.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":143848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":143848,"derivative":{"exercise_price":0.41,"exercise_date":"2024-05-11","underlying":"Common Stock","underlying_shares":143848},"source":{"system":"sec-edgar","filing":"0001062993-23-011115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323011115/form4.xml","form_type":"4"}},{"id":1894275,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T16:32:00.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":143848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":143848,"derivative":{"exercise_price":0.41,"exercise_date":"2024-05-11","underlying":"Common Stock","underlying_shares":143848},"source":{"system":"sec-edgar","filing":"0001062993-23-011112","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/941871/000106299323011112/form4.xml","form_type":"4"}},{"id":1893254,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":89874,"kind":"person","name":"Yanni Barbara","position":1,"cik":"0001610561","reported_name":"Yanni Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T16:31:30.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":143848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":143848,"derivative":{"exercise_price":0.41,"exercise_date":"2024-05-11","underlying":"Common Stock","underlying_shares":143848},"source":{"system":"sec-edgar","filing":"0001062993-23-011110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323011110/form4.xml","form_type":"4"}},{"id":1893253,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T16:31:05.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":143848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":143848,"derivative":{"exercise_price":0.41,"exercise_date":"2024-05-11","underlying":"Common Stock","underlying_shares":143848},"source":{"system":"sec-edgar","filing":"0001062993-23-011108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323011108/form4.xml","form_type":"4"}},{"id":1932062,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:35:42.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.3995,"expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001062993-23-008326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323008326/form4.xml","form_type":"4"}},{"id":1932619,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91078,"kind":"person","name":"Evans Elizabeth E.","position":1,"cik":"0001863447","reported_name":"Evans Elizabeth E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:35:09.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":40000,"derivative":{"exercise_price":0.3995,"expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001062993-23-008325","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863447/000106299323008325/form4.xml","form_type":"4"}},{"id":1932544,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:34:57.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":32107,"price":0.27,"value":8668.89,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":32107,"derivative":{"exercise_price":0.3995,"exercise_date":"2023-03-31","expiration_date":"2033-03-28","underlying":"Common Stock","underlying_shares":32107},"source":{"system":"sec-edgar","filing":"0001062993-23-008324","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323008324/form4.xml","form_type":"4"}},{"id":1932145,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-03T16:34:03.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":4146341,"price":0.41,"value":1699999.81,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":19505352,"source":{"system":"sec-edgar","filing":"0001062993-23-008323","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299323008323/form4.xml","form_type":"4"}},{"id":1932545,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:33:20.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":40000,"derivative":{"exercise_price":0.3995,"expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001062993-23-008322","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000106299323008322/form4.xml","form_type":"4"}},{"id":1932059,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:32:43.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":32000,"derivative":{"exercise_price":0.3995,"expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001062993-23-008321","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323008321/form4.xml","form_type":"4"}},{"id":1932061,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:31:57.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":56000,"derivative":{"exercise_price":0.4395,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001062993-23-008320","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323008320/form4.xml","form_type":"4"}},{"id":1932060,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-03T16:31:57.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":731707,"price":0.41,"value":299999.87,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":5142691,"source":{"system":"sec-edgar","filing":"0001062993-23-008320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323008320/form4.xml","form_type":"4"}},{"id":2068092,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T16:30:35.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":19852,"price":0.44,"value":8734.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2022. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":19852,"derivative":{"exercise_price":0.645,"exercise_date":"2022-12-31","expiration_date":"2032-12-28","underlying":"Common Stock","underlying_shares":19852},"source":{"system":"sec-edgar","filing":"0001062993-23-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323000300/form4.xml","form_type":"4"}},{"id":2093141,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-07T16:30:51.000Z","date":"2022-12-06","kind":"other","acquired":true,"shares":3988,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":181736,"source":{"system":"sec-edgar","filing":"0001062993-22-023491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322023491/form4.xml","form_type":"4"}},{"id":2103392,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-28T16:35:57.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":1511430,"price":0.5293,"value":799999.899,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4410984,"source":{"system":"sec-edgar","filing":"0001062993-22-022815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322022815/form4.xml","form_type":"4"}},{"id":2103267,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78318,"kind":"organization","name":"FCMI Parent Co.","position":2,"cik":"0001678258","reported_name":"FCMI Parent Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-28T16:35:03.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":3778575,"price":0.5293,"value":1999999.7475,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":15359011,"source":{"system":"sec-edgar","filing":"0001062993-22-022816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000106299322022816/form4.xml","form_type":"4"}},{"id":2103435,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-28T16:33:48.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":188928,"price":0.5293,"value":99999.5904,"ownership":{"direct":false,"nature":"By Gee Eff Services Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Frieberg is the sole owner and President of Gee Eff Services Limited."}],"balance_after":193049,"source":{"system":"sec-edgar","filing":"0001062993-22-022814","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322022814/form4.xml","form_type":"4"}},{"id":2103246,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-28T16:33:02.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":47232,"price":0.5293,"value":24999.8976,"ownership":{"direct":true},"balance_after":67232,"source":{"system":"sec-edgar","filing":"0001062993-22-022813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322022813/form4.xml","form_type":"4"}},{"id":2147517,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-03T16:15:48.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":26260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2022. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":26260,"derivative":{"exercise_price":0.495,"exercise_date":"2022-09-30","expiration_date":"2032-09-27","underlying":"Common Stock","underlying_shares":26260},"source":{"system":"sec-edgar","filing":"0001062993-22-020146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322020146/form4.xml","form_type":"4"}},{"id":2217385,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T16:30:34.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":12064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2022. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":12064,"derivative":{"exercise_price":1.08,"exercise_date":"2022-06-30","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":12064},"source":{"system":"sec-edgar","filing":"0001062993-22-015746","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322015746/form4.xml","form_type":"4"}},{"id":2272200,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91077,"kind":"person","name":"Stecyk Chrystyna Bedrij","position":1,"cik":"0001811625","reported_name":"Stecyk Chrystyna Bedrij","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:46:51.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":53254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":53254,"derivative":{"exercise_price":1.12,"exercise_date":"2023-05-12","underlying":"Common Stock","underlying_shares":53254},"source":{"system":"sec-edgar","filing":"0001062993-22-012390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811625/000106299322012390/form4.xml","form_type":"4"}},{"id":2271725,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:43:53.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":53254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":53254,"derivative":{"exercise_price":1.12,"exercise_date":"2023-05-12","underlying":"Common Stock","underlying_shares":53254},"source":{"system":"sec-edgar","filing":"0001062993-22-012388","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322012388/form4.xml","form_type":"4"}},{"id":2272786,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:41:49.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":53254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":53254,"derivative":{"exercise_price":1.12,"exercise_date":"2023-05-12","underlying":"Common Stock","underlying_shares":53254},"source":{"system":"sec-edgar","filing":"0001062993-22-012386","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/941871/000106299322012386/form4.xml","form_type":"4"}},{"id":2271721,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":89874,"kind":"person","name":"Yanni Barbara","position":1,"cik":"0001610561","reported_name":"Yanni Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:39:46.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":53254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":53254,"derivative":{"exercise_price":1.12,"exercise_date":"2023-05-12","underlying":"Common Stock","underlying_shares":53254},"source":{"system":"sec-edgar","filing":"0001062993-22-012385","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322012385/form4.xml","form_type":"4"}},{"id":2272152,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:37:32.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":53254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":53254,"derivative":{"exercise_price":1.12,"exercise_date":"2023-05-12","underlying":"Common Stock","underlying_shares":53254},"source":{"system":"sec-edgar","filing":"0001062993-22-012384","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322012384/form4.xml","form_type":"4"}},{"id":2308476,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:37:31.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":20000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001062993-22-009451","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000106299322009451/form4.xml","form_type":"4"}},{"id":2307641,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:36:15.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":16000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001062993-22-009450","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322009450/form4.xml","form_type":"4"}},{"id":2307639,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:34:54.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":28000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001062993-22-009448","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322009448/form4.xml","form_type":"4"}},{"id":2308760,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91078,"kind":"person","name":"Evans Elizabeth E.","position":1,"cik":"0001863447","reported_name":"Evans Elizabeth E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:33:18.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":20000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001062993-22-009446","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863447/000106299322009446/form4.xml","form_type":"4"}},{"id":2307638,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114852,"kind":"person","name":"Royer Scott E.","position":1,"cik":"0001747756","reported_name":"Royer Scott E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:32:04.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":16000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001062993-22-009444","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322009444/form4.xml","form_type":"4"}},{"id":2308475,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:30:24.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":10032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2022. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":10032,"derivative":{"exercise_price":1.32,"exercise_date":"2022-03-31","expiration_date":"2032-03-28","underlying":"Common Stock","underlying_shares":10032},"source":{"system":"sec-edgar","filing":"0001062993-22-009441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322009441/form4.xml","form_type":"4"}},{"id":2374342,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T16:37:01.000Z","date":"2022-02-23","kind":"purchase","acquired":true,"shares":18000,"price":1.32,"value":23760.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001062993-22-005567","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322005567/form4.xml","form_type":"4"}},{"id":2374341,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T16:37:01.000Z","date":"2022-02-23","kind":"purchase","acquired":true,"shares":2000,"price":1.3,"value":2600.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001062993-22-005567","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322005567/form4.xml","form_type":"4"}},{"id":2421163,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-31T16:26:28.000Z","date":"2022-01-27","kind":"purchase","acquired":true,"shares":90090,"price":1.11,"value":99999.9,"ownership":{"direct":false,"nature":"By Benbow Estates, Ltd."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":94510,"source":{"system":"sec-edgar","filing":"0001062993-22-001868","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322001868/form4.xml","form_type":"4"}}],"next_cursor":"2022-01-31T16:26:28.000000Z,2421163"}